|
3777
|
(R)-AS-1
|
First-in-class highly selective and orally bioavailable PAM of EAAT2 |
€145.00 |
|
3957
|
A-1155463 dihydrochloride
|
BH3 mimetic Ligand of BCL protein BCL-XL |
Inquire |
|
3956
|
ABBV-744
|
First-in-class highly BDII (Bromodomain II)-selective BET bromodomain inhibitor |
Inquire |
|
3946
|
Altiratinib
|
Balanced inhibitor for MET, TIE2 (TEK), and VEGFR2 (KDR) kinases |
Inquire |
|
3945
|
AMG-337
|
Potent and exquisitely selective inhibitor of wild-type and some mutant forms of c-Met |
Inquire |
|
3944
|
ARV-825
|
Potent and selective protein BRD4 degrader |
Inquire |
|
3943
|
AVN944
|
Incompetitive small molecule inhibitor of inosine monophosphate dehydrogenase (IMPDH) |
Inquire |
|
3942
|
BAY-1082439
|
PI3Kα/β-balanced inhibitor |
Inquire |
|
3845
|
BAY-1797
|
Potent and selective P2X4 inhibitor |
€130.00 |
|
3906
|
CA77.1
|
Orally bioavailable and brain-penetrant CMA activator |
€90.00 |
|
3926
|
CID 5157334
|
Selective surrogate agonist for GPR27 |
€95.00 |
|
3960
|
EPZ-5676
|
Selective and S-adenosyl methionine (SAM) competitive inhibitor of DOT1L methyltransferase |
Inquire |
|
3843
|
LYN-1604 dihydrochloride
|
Potent ULK1 agonist |
€130.00 |
|
3910
|
MitoBloCK-10
|
Tim44 inhibitor |
€90.00 |
|
3909
|
NFATc1 inhibitor A04
|
Potent RANKL-induced osteoclastogenesis inhibitor |
€90.00 |
|
3907
|
PEO-IAA
|
IAA and auxin antagonist |
€60.00 |
|
3961
|
PF-03758309
|
Potent and ATP-competitive inhibitor of p21-activated kinase (PAK4) |
Inquire |
|
3951
|
Senicapoc
|
Potent and selective antagonist of the Gardos channel |
€65.00 |
|
3908
|
Sirtinol
|
Specific SIRT inhibitor |
€90.00 |
|
3824
|
TEAD inhibitor TM2
|
Potent reversible pan-TEAD inhibitor |
€130.00 |
|
3810
|
TPP-UNC-CA157
|
Highly specific and potent COQ8 inhibitor |
€135.00 |
|
3958
|
Uprosertib
|
Selective and ATP-competitive pan-Akt (PKB) inhibitor |
Inquire |
|
3905
|
USP14 inhibitor IU1
|
Selective and reversible inhibitor of Usp14 |
€85.00 |